ALDH1A3 and type 2 diabetes mellitus: To support these conclusions and validate the translational relevance of these findings, we administered a novel selective ALDH1A3 inhibitor, KOTX1, to db/db or diet-induced diabetic mice (DIO) as well as human T2D islets, and show that it improved glucose control, increased insulin secretion, and enhanced glucose tolerance.